Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;24(9):1633-1635.
doi: 10.1002/ejhf.2633. Epub 2022 Aug 2.

Tolerability and safety barriers to sodium-glucose cotransporter 2 inhibitor initiation in heart failure with reduced ejection fraction

Husam M Salah  1 , Marat Fudim  2   3
Affiliations
Editorial

Tolerability and safety barriers to sodium-glucose cotransporter 2 inhibitor initiation in heart failure with reduced ejection fraction

Husam M Salah et al. Eur J Heart Fail. 2022 Sep.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Bottle A, Newson R, Faitna P, Hayhoe B, Cowie MR. Changes in heart failure management and long-term mortality over 10 years: observational study. Open Heart. 2022;9:e001888.
    1. Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, et al. Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. ESC Heart Fail. 2022;9:947-52.
    1. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, et al. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes - systematic review and meta-analysis of randomized placebo-controlled trials. Am Heart J. 2021;232:10-22.
    1. Butler J, Usman MS, Khan MS, Greene SJ, Friede T, Vaduganathan M, et al. Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis. ESC Heart Fail. 2020;7:3298-309.
    1. Salah HM, Verma S, Santos-Gallego CG, Bhatt AS, Vaduganathan M, Khan MS, et al. Sodium-glucose cotransporter 2 inhibitors and cardiac remodeling. J Cardiovasc Transl Res. 2022. https://doi.org/10.1007/s12265-022-10220-5.